Gammadelta+ T cells play a crucial role in determining disease susceptibility and modulating the adaptive immune response in Coxsackievirus-induced myocarditis.
Answers are grounded in this paper and cite their sources.
Should not alter myocarditis management; hypothesis-generating for gammadelta+ T-cell targeting and requires prospective validation.
Myocarditis is a complex disease in which distinct immunopathogenic mechanisms cause tissue injury. In some but not all cases, autoimmunity is a major pathogenic factor. Cross-reactivity between viral and myosin epitopes underlies both cellular and humoral autoimmunity in myocarditis. Thus, the genetics of the host as well as the virus determine disease pathogenicity. Innate immunity, as represented by gammadelta+ T cells, is important in determining disease susceptibility. The innate effectors rapidly localize in the infected myocardium and through release of IFNgamma (Vgamma4+ cells; BALB/c) or IL-4 (Vgamma1+ cells; C57Bl/6), modulate the developing adaptive immune response to either a Th1 or Th2 response, respectively. The Vgamma4+ cells in BALB/c mice recognize CD1d, a major histocompatibility complex class I-like antigen. The ligand for Vgamma1+ cells is unknown. Only infected myocytes up-regulate CD1d. Signaling through both infection (double stranded RNA) and TNFalpha is required for CD1d up-regulation.
No takes yet. Share an insight, caveat, or question.
Sally A. Huber (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: